Free product CJC-1295 with DAC

CJC-1295 with DAC

A longer-lasting approach to growth hormone research

CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH), studied for its effects on growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signalling.

What does “with DAC” mean?

DAC stands for Drug Affinity Complex. This modification allows the peptide to bind to albumin, a protein in the blood, extending its time in circulation. This longer duration is a defining feature of CJC-1295 with DAC. (pubmed.ncbi.nlm.nih.gov)

What has research shown?

Early controlled studies in healthy adults found sustained increases in GH and IGF-1 following CJC-1295 administration. A separate study found that the natural pulsatile pattern of GH release persisted during this prolonged stimulation. These findings support its relevance to research into the GH/IGF-1 pathway. (pubmed.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)

These hormone findings do not establish benefits for muscle gain, fat loss, recovery or anti-aging. Long-term safety and effectiveness for those purposes remain unproven.

Is it the same as CJC-1295 without DAC?

No. Products labelled “CJC-1295 without DAC” commonly refer to modified GRF (1–29), a different, shorter-acting peptide. The names should not be treated as interchangeable.

Explore CJC-1295 with DAC at STAR LABS

Review the product specifications and ask us about available batch-specific testing documentation before ordering.

For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease. Information provided is educational and is not medical advice.